TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $12.3K2009: $12.19M2010: $33.32M2011: $22.21M2012: $4.35M2013: $5.50M2014: $29.49M2015: $42.23M2016: $22.09M2017: $36.84M2018: $23.59M2019: $9.50M2020: $32.59M2021: $55.74M2022: $11.36M2023: $35.44M2024: $45.79M2025: $40.79M$40.79M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$40.79M-10.9%
2024$45.79M+29.2%
2023$35.44M+212.1%
2022$11.36M-79.6%
2021$55.74M+71.1%
2020$32.59M+243.1%
2019$9.50M-59.7%
2018$23.59M-36.0%
2017$36.84M+66.8%
2016$22.09M-47.7%
2015$42.23M+43.2%
2014$29.49M+436.5%
2013$5.50M+26.3%
2012$4.35M-80.4%
2011$22.21M-33.3%
2010$33.32M+173.4%
2009$12.19M+99167.7%
2008$12.3K—